Martingale Asset Management L P Kodiak Sciences Inc. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$4.3 - $9.48 $12,504 - $27,567	-2,908 Reduced 4.8%	57,729 $398,000
Q1 2023 May 12, 2023	BUY	$4.81 - $8.88 $88,619 - $163,605	18,424 Added 43.65%	60,637 $375,000
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.05 $93,927 - $115,968	14,406 Added 51.81%	42,213 $302,000
Q3 2022 Nov 14, 2022	BUY	$7.57 - $12.5 $109,159 - $180,250	14,420 Added 107.72%	27,807 $216,000
Q2 2022 Aug 11, 2022	BUY	$5.04 - $9.48 $67,470 - $126,908	13,387 New	13,387 $102,000

104

39.8M

7.6K

3.5K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $138M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.